VTX-2337
| CAS号 | 926927-61-9 | 货号 | BCP16667 |
| 中文名 | VTX-2337 | ||
| 英文名 | VTX-2337 | ||
| 中文别名 | |||
| 英文别名 | VTX 2337;VTX2337;Motolimod; | ||
| 分子式 | C28H34N4O2 | 分子量 | 458.6 |
| 生物活性 | VTX-2337 selectively activates TLR8 with an EC(50) of about 100 nmol/L and stimulates production of TNFα and interleukin (IL)-12 from monocytes and myeloid dendritic cells (mDC). VTX-2337 stimulates IFNγ production from NK cells and increases the cytotoxicity of NK cells against K562 and ADCC by rituximab and trastuzumab. Effects of VTX-2337 on NK cells were, in part, from direct activation as increased IFNγ production and cytotoxic activity were seen with purified NK cells. Finally, VTX-2337 augments ADCC by rituximab in PBMCs with different FcγR3A genotypes (V/V, V/F, and F/F at position 158). VTX-2337 is a novel small-molecule TLR8 agonist that activates monocytes, DCs, and NK cells. | ||
| 信号通路 | Others Pathway | ||
| 靶 点 | TLR | ||
结构式
本页面部分数据来自于公开的网络资源,所以瀚香生物不能保证其准确性。
不同批次的产品详情请咨询我们的客服：
- 全国免费电话：400-099-8200
- 在线客服:
瀚香生物（Biochempartner) 的所有产品和服务仅用于科学研究，禁止用于人体和治疗！